Conversely, the downregulation of Sterol Regulatory Element-Binding Transcription Factor 1 (Srebf1), which regulates lipid homeostasis, reflects impaired lipid production, potentially contributing to metabolic disorders such as non-alcoholic fatty liver disease (NAFLD)53,54. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.